Taxotere
Taxotere Official FDA information, side effects and uses.
Posted by Taxotere (Taxotere) on Sun, 09 Sep 2007 23:16:23 +0000
sanofi-aventis announced that a meta-analysis of individual patient data (IPD) including 2,867 patients from seven clinical trials demonstrated a significant overall survival (OS) benefit of Taxotere (docetaxel injection concentrate) over vinca-alkaloid-based regimens in the treatment of first line advanced Non Small Cell Lung Cancer (NSCLC) patients.
(AFX UK Focus) 2007-09-04 07:13 GMT: Sanofi-Aventis says Taxotere shows good results in non-small cell lung cancer (Interactive Investor)
PARIS (Thomson Financial) - Pharmaceutical company Sanofi-Aventis said seven trials of its Taxotere drug in treating non-small cell lung cancer showed a "significant" improvement in overall survival rates versus existing treatments.
Prostate Cancer Treatment To Be Listed On PBS, Australia (Medical News Today)
Taxotere® (docetaxel) will be available on the Pharmaceutical Benefits Scheme (PBS) from 1 November 2007 for the treatment of patients with androgen independent (hormone refractory) prostate cancer (AIPC). Prostate cancer is the most common cancer in Australian men and the second leading cause of male cancer deaths, after lung cancer. [click link for full article]
Prostate cancer drug aid a lifeline (Warrnambool Standard)
SOUTH-WEST men diagnosed with prostate cancer, like Warrnambool's John ``Flags'' O'Flaherty, will no longer have to pay up to $18,000 for a drug which prolongs and improves their quality of life.
Arius Features Preclinical Data on Antibody Candidates at Two Conferences (CNW Group via Yahoo! Finance)
ARIUS Research Inc., , a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that it will deliver poster presentations at two scientific conferences reporting preclinical data for two of its anti-cancer antibody drug candidates....
Posted by Taxotere (Taxotere) on Fri, 07 Sep 2007 00:16:40 +0000
Pharmacyclics Inc. shares rose Wednesday after the company reported encouraging data from three mid-stage clinical trials of Xcytrin, its lead cancer drug candidate.
European Indexes Advance (BusinessWeek Online via Yahoo! Asia News)
Gains Tuesday were fueled by strength on Wall Street
Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients (The San Francisco Examiner)
Sep 5, 2007 7:30 AM (5 hrs ago) From Pharmacyclics, Inc., Distributed by PR Newswire
Poniard Pharmaceuticals Announces Updated Results Of Picoplatin Phase 2 Trial Demonstrating Survival Benefit In Small ... (Medical News Today)
Poniard Pharmaceuticals, Inc. [click link for full article]
Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients (PR Newswire via Yahoo! Finance)
Pharmacyclics, Inc. today announced results from three open-label, multi-center Phase 2 clinical trials evaluating Xcytrin® Injection, the company's lead product candidate, as a single-agent and in combination with chemotherapy as a second-line treatment for patients with non-small cell lung cancer who failed at least one platinum-based chemotherapy regimen....
Posted by Taxotere (Taxotere) on Tue, 04 Sep 2007 23:15:59 +0000
PARIS (Thomson Financial) - Pharmaceutical company Sanofi-Aventis said seven trials of its Taxotere drug in treating non-small cell lung cancer showed a 'significant' improvement in overall survival rates versus existing treatments.
Sanofi presents promising data on Taxotere and Lovenox
Sanofi-Aventis has revealed positive results from a meta-analysis which reveal the survival benefit of regimens based on the firm’s Taxotere in patients with non small cell lung cancer...
Taxotere is Listed on the Pharmaceutical Benefits Scheme
The Pharmaceutical Benefits Scheme (PBS) has finally listed Taxotere for men with hormone refractory prostate cancer. Now, our brothers in Australia will not have to personally pay to obtain their Taxotere. Up until this point, ...
Combinations of Proteasome Inhibitor Velcade with Chemo or ...
The folks at the University of California at Davis have done a good deal of lab work that suggests that velcade before taxotere may be detrimental, but that taxotere before velcade may lead to a potentiation of anticancer effects. ...
Questions and Concerns about Consolidation Taxotere
Although consolidation taxotere after concurrent chemo and radiation therapy (CT/RT) emerged as the preferred treatment approach for about 2/3 of American oncologists over the last few years, this was predicated on an incomplete story. ......
Posted by Taxotere (Taxotere) on Sat, 01 Sep 2007 00:16:00 +0000
NICE uphold ban on lung cancer drug Legal & Medical Magazine, UK - ... compared with either docetaxel (Taxotere) or best supportive care, and therefore concluded that the drug is not an effective use of NHS resources. ... |
Prostate patient in battle of his life - with a committee - Sydney Morning Herald
 Sydney Morning Herald | Prostate patient in battle of his life - with a committee Sydney Morning Herald, Australia - Tony Sonneveld wants federal funding for the drug Taxotere extended to give men like him a few months longer to live. HE HAS walked the Kokoda Trail and run ... |
Clinical Trials Update... Original post: NICE uphold ban on lung cancer drug - Legal & Medical Magazine by ©2007 Google at taxotere - Google News
Posted by Taxotere (Taxotere) on Fri, 24 Aug 2007 23:16:06 +0000
MSN MoneyCentral - Poniard is also evaluating intravenous picoplatin in an ongoing Phase 1 clinical trial as a first-line treatment for metastatic colorectal cancer and in an ongoing Phase 2 trial in combination with docetaxel (Taxotere(R)) and prednisone in ...
Cytotoxics remain standard bearers
BioPortfolio - Datamonitor forecasts the cytotoxic market size to grow to a peak of nearly $13 billion by 2010, mainly driven by the growth of Eli Lilly's Gemzar, and Sanofi-Aventis' Taxotere and Eloxatin. Currently, these drugs alone account for 34% of total ...
Firm loses lung cancer drug appeal
Channel 4 News - The independent appraisal committee was not persuaded that the evidence presented provided a robust demonstration of the clinical and cost effectiveness of pemetrexed compared with either docetaxel (Taxotere) or best supportive care and therefore ...
MethylGene Reports Second Quarter 2007 Results
Market Wire - Expect to initiate additional MGCD0103 clinical trials: a Phase I combination trial with Taxotere ® in solid tumors (Trial 011) and a Phase II combination trial with Vidaza ® in lymphomas (Trial 012). The latter trial will include a run-in ...
Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To ...
San Francisco Examiner - Ortataxel (14-beta-hydroxydeacetylbaccatin) belongs to a new generation of taxanes with the potential to be active in tumors resistant to Bristol-Myers Squibb's Taxol(R) (paclitaxel) and Sanofi-Aventis' Taxotere(R) (docetaxel). The bioavailability of ... ...
Posted by Taxotere (Taxotere) on Wed, 22 Aug 2007 23:17:41 +0000
GPC Biotech Shares Fall on US FDA Panel's Vote on Cancer Drug Bloomberg - Similar therapies, such as Sanofi-Aventis SA's Taxotere, must be given intravenously. Taxotere, from Paris-based Sanofi, is now the only approved treatment ... |
Cell Genesys’ GVAX: A Multi-Trick Pony - Seeking Alpha
Cell Genesys’ GVAX: A Multi-Trick Pony Seeking Alpha, NY - The most impressive performance was achieved by combining Taxotere and Celgene's Thalidomide, which resulted in a median survival of 25.9 months compared ... |
Pharmacyclics Reports Fourth Quarter and Fiscal 2007 Financial Results - CNNMoney.com
Pharmacyclics Reports Fourth Quarter and Fiscal 2007 Financial Results
CNNMoney.com - In the Alimta trial (n=27), 1... Original post: GPC Biotech Shares Fall on US FDA Panel's Vote on Cancer Drug - Bloomberg by ©2007 Google at taxotere - Google News
A Bounty of Ideas from Berkshire's Portfolio (Morningstar.com via Yahoo! Finance)
Posted by Taxotere (Taxotere) on Wed, 22 Aug 2007 00:16:17 +0000 A look at Berkshire's 5-star holdings.
Taxotere® Treats Five Tumor Types
Posted by Taxotere (Taxotere) on Tue, 21 Aug 2007 23:16:37 +0000 Taxotere® in combination with cisplatin and fluorouracil for the induction ... Taxotere (docetaxel) Label What is the most important information about Taxotere' ... people who take Taxotere have severe fluid retention, ... nurse prior ...
Clinical Trials Update: Aug. 20, 2007 (HealthDay via Yahoo! News)
Posted by Taxotere (Taxotere) on Tue, 21 Aug 2007 13:04:07 +0000 (HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Hotlinks (Tiscali)
Posted by Taxotere (Taxotere) on Tue, 21 Aug 2007 00:15:32 +0000 It is the first of four cancer drugs that Glaxo hopes to have approved by 2010. Studies of Tykerb, or lapatinib, to treat early-stage and inflammatory breast cancers, as well as head/neck, gastric and lung cancers, are also underway. Pages: Start 1 2 
|